Vitruvian Partners LLP Long-Term Concentrated

Location: London, United Kingdom

CIK: 0001692590 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 11, 2026

Total Value: $112M (100.0% shares, 0.0% debt)

Holdings (7)

HNGE HINGE HEALTH INC 43.1%

Value $48.2M Shares 1,250,000 Est. Cost $40.42 Unrealized +0.4%

MQ MARQETA 25.0%

Value $27.96M Shares 6,853,183 Est. Cost $29.82 Unrealized -85.5%

CARG CARGURUS INC 14.4%

Value $16.1M Shares 472,959 Est. Cost $29.39 Unrealized +10.1%

XMTR XOMETRY INC 7.0%

Value $7.838M Shares 191,919 Est. Cost $25.01 Unrealized +142.3%

GLBE GLOBAL-E 5.8%

Value $6.485M Shares 210,209 Est. Cost $44.64 Unrealized -18.9%

MXCT MAXCYTE 3.2%

Value $3.543M Shares 5,043,356 Est. Cost $12.03 Unrealized -91.4%

RXST RXSIGHT 1.5%

Value $1.718M Shares 278,865 Est. Cost $34.28 Unrealized -73.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
HNGE	HINGE HEALTH INC	1,250,000	$48.2M	43.1%	$40.42	+0.4%	CL A	433313103
MQ	MARQETA	6,853,183	$27.96M	25.0%	$29.82	-85.5%	CLASS A COM	57142B104
CARG	CARGURUS INC	472,959	$16.1M	14.4%	$29.39	+10.1%	COM CL A	141788109
XMTR	XOMETRY INC	191,919	$7.838M	7.0%	$25.01	+142.3%	CLASS A COM	98423F109
GLBE	GLOBAL-E	210,209	$6.485M	5.8%	$44.64	-18.9%	SHS	M5216V106
MXCT	MAXCYTE	5,043,356	$3.543M	3.2%	$12.03	-91.4%	COM	57777K106
RXST	RXSIGHT	278,865	$1.718M	1.5%	$34.28	-73.6%	COM	78349D107